Carborane‐Based Analogs of Celecoxib and Flurbiprofen, their COX Inhibition Potential, and COX Selectivity Index
Open Access
- 4 May 2025
- journal article
- Published by Wiley in ChemMedChem
- Vol. 20 (11) , e202500166
Abstract
The cylcooxygenase isoforms COX‐1 and COX‐2 are involved in the production of prostaglandins in physiological and pathological processes. The overexpression of COX‐2 under inflammatory conditions, its role in cancer and neurodegenerative diseases necessitates the need to develop and improve nonsteroidal anti‐inflammatory drugs. These mainly unselective COX inhibitors, e.g. aspirin, are used to reduce the symptoms of inflammation. To reduce unwanted side effects connected with unselective inhibition, the development of novel COX‐2 selective inhibitors is a major goal. Herein, the synthesis, characterization and in vitro biological evaluation of eight flurbiprofen‐ and celecoxib‐based carborane analogs are described. Carboranes as hydrophobic surrogates are suitable substituents that can contribute to a selectivity increase toward COX‐2 due to size exclusion. The inhibitory efficacy for COX‐1 and COX‐2 of the four ortho‐ and four nido‐carborane derivatives has been tested. The nido compounds are much more potent than their closo‐carborane analogs. The celecoxib‐based nido‐carborane compound 10 shows an IC50(COX‐2) value in the sub‐μM range and slight selectivity for COX‐2. This is in contrast to its ortho‐carborane counterpart 9, which shows an inhibition preference for COX‐1. While none of these carborane derivatives outperforms their organic analogs, the flurbiprofen‐based nido‐carborane derivatives 14a and 14b surpass the known carborane‐based flurbiprofen analogs.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (He 1376/54‐1, PI‐304/7‐1)
- Bundesministerium für Forschung, Technologie und Raumfahrt (314061271‐CRC/TRR 205/1‐2, 031L0258B)
This publication has 76 references indexed in Scilit:
- A turbulent decade for NSAIDs: update on current concepts of classification, epidemiology, comparative efficacy, and toxicityRheumatology International, 2011
- Carbaboranes as Pharmacophores: Properties, Synthesis, and Application StrategiesChemical Reviews, 2011
- Synthesis and evaluation of carbaborane derivatives of indomethacin as cyclooxygenase inhibitorsBioorganic & Medicinal Chemistry, 2011
- Preparation, Characterization, and Screening of a High Affinity Organometallic Probe for α-Adrenergic ReceptorsJournal of Medicinal Chemistry, 2011
- Incorporation ofortho-Carbaboranyl-Nε-Modifiedl-Lysine into Neuropeptide Y Receptor Y1- and Y2-Selective AnaloguesJournal of Medicinal Chemistry, 2011
- Asborin: The Carbaborane Analogue of AspirinChemMedChem, 2009
- Permeability of the Blood-Brain Barrier to a RhenacarboraneThe Journal of Pharmacology and Experimental Therapeutics, 2009
- A new consecutive three-component oxazole synthesis by an amidation–coupling–cycloisomerization (ACCI) sequenceChemical Communications, 2006
- Cesium Effect: High Chemoselectivity in Direct N-Alkylation of AminesThe Journal of Organic Chemistry, 2002
- Potent estrogen agonists based on carborane as a hydrophobic skeletal structureChemistry & Biology, 2001